GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 97 filers reported holding GOSSAMER BIO INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,902 | -30.6% | 33,504 | 0.0% | 0.00% | – |
| Q2 2023 | $40,205 | +50.9% | 33,504 | +58.4% | 0.00% | – |
| Q1 2023 | $26,650 | -45.5% | 21,151 | -6.1% | 0.00% | – |
| Q4 2022 | $48,868 | -77.4% | 22,520 | +25.0% | 0.00% | – |
| Q3 2022 | $216,000 | +40.3% | 18,009 | -1.9% | 0.00% | – |
| Q2 2022 | $154,000 | -18.5% | 18,351 | +22.3% | 0.00% | – |
| Q3 2021 | $189,000 | +33.1% | 15,001 | -14.0% | 0.00% | – |
| Q2 2021 | $142,000 | -9.0% | 17,436 | +3.5% | 0.00% | – |
| Q1 2021 | $156,000 | +3.3% | 16,850 | +7.6% | 0.00% | – |
| Q4 2020 | $151,000 | -9.6% | 15,665 | +16.6% | 0.00% | – |
| Q3 2020 | $167,000 | -8.7% | 13,436 | -4.7% | 0.00% | – |
| Q2 2020 | $183,000 | +77.7% | 14,100 | +38.5% | 0.00% | – |
| Q1 2020 | $103,000 | – | 10,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
| Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
| Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
| Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
| Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
| HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
| MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
| Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
| Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |